Similar articles

• [Clinical,manifestations of the myopathies due to deletions/mutations of the dystrophin gene].

  Bonilla E, Minetti C, Chang HW, Medori R, Cordone G, Di Mauro S. Bonilla E, et al. Minerva Pediatr. 1991 Mar;43(3):67-70. Minerva Pediatr. 1991. PMID: 1870528 Italian. No abstract available.
• Identification of a point mutation and germinal mosaicism in a Duchenne muscular dystrophy family.

  Wilton SD, Chandler DC, Kakulas BA, Laing NG. Wilton SD, et al. Hum Mutat. 1994;3(2):133-40. doi: 10.1002/humu.1380030208. Hum Mutat. 1994. PMID: 8199594
• Dystrophin deficiency in a case of congenital myopathy.

  Prelle A, Medori R, Moggio M, Chan HW, Gallanti A, Scarlato G, Bonilla E. Prelle A, et al. J Neurol. 1992 Feb;239(2):76-8. doi: 10.1007/BF00862976. J Neurol. 1992. PMID: 1552307
• [Regulation of human DMD gene expression. An example of multiple utilization of genetic information].

  Napierała D, Słomski R. Napierała D, et al. Postepy Biochem. 1998;44(1):48-55. Postepy Biochem. 1998. PMID: 9738237 Review. Polish. No abstract available.
• [Dystrophinopathies: concept and diagnostic methodology].

  Teijeira S, Navarro C. Teijeira S, et al. Neurologia. 1994 May;9(5):191-7. Neurologia. 1994. PMID: 8024825 Review. Spanish. No abstract available.